Dozens Of New Cancer Drugs Do Little To Improve Survival, Frustrating Patients
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.
The independent source for health policy research, polling, and news.
Showing 101 - 112 of 112
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.
Mammograms find many slow-growing cancers that aren’t life-threatening and shouldn’t be treated, a Danish study said.
Investigators claim drugmaker employees met in secret at restaurants, golf outings and at “Girls Night Out” to raise generic drug prices.
A new study shows women fare worse without a support network.
The U.S. Senate passed a landmark bill to help millions of Americans suffering from mental illness.
Sponsors of Congressional action up for vote Wednesday have championed mental health changes since the 2012 Newtown shootings.
Providing regular care at a Texas clinic prevents patients from cycling back to the hospital in a psychiatric crisis.
Education and better heart health may deserve credit.
A deadly superbug has been linked to at least four deaths and nine other cases in the U.S. and has spread across the globe in just six years.
Ending pain and suffering has helped several states pass “right-to-die” laws, but dying patients are more concerned about controlling how they die and dying with dignity.
Ten-year-old Josh Hardy died last month. His struggle to survive helped to spur laws to get unapproved drugs to the terminally ill.
The FDA, reacting to lobbying by patients and families, has approved a drug for Duchenne muscular dystrophy, a rare and lethal disease.
Stay informed by signing up for the Morning Briefing and other emails:
© 2026 KFF